InChI=1S/C22H32O5/c23- 19- 13- 7- 11- 17- 21(25) 16- 10- 6- 5- 9- 15- 20(24) 14- 8- 3- 1- 2- 4- 12- 18- 22(26) 27/h2- 11,15- 16,20- 21,23- 25H,1,12- 14,17- 19H2,(H,26,27) /b4- 2- ,6- 5+,8- 3- ,11- 7- ,15- 9+,16- 10- /t20- ,21- /m1/s1 |
RXZULUQRGUAOLG-OCDBVANQSA-N |
OC(CC/C=C\C/C=C\C[C@H](\C=C\C=C\C=C/[C@H](C/C=C\CCO)O)O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
(4Z,7Z,10R,11E,13E,15Z,17S,19Z)- 10,17,22- trihydroxydocosa- 4,7,11,13,15,19- hexaenoic acid
|
(4Z,7Z,10R,11E,13E,15Z,17S,19Z)- 10,17,22- trihydroxydocosahexaenoic acid
|
ChEBI
|
10(R),17(S),20- trihydroxydocosa- 4Z,7Z,11E,13E,15Z,19Z- hexaenoic acid
|
ChEBI
|
22-hydroxy-(neuro)protectin D1
|
ChEBI
|
22-hydroxyneuroprotectin D1
|
ChEBI
|
22-OH-(N)PD1
|
SUBMITTER
|
22-OH-PD1
|
ChEBI
|
27632053
|
Reaxys Registry Number
|
Reaxys
|
|